Drugs / V205C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00109278 | Oct 2004 → May 2005 | measles | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V205C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00109278 ↗ |
| Modality | Vaccine | “V205C, measles, mumps, and rubella virus vaccine live” NCT00109278 ↗ |